Tag: preclinical

instylla

Instylla announces positive results from preclinical studies of Embrace hydrogel embolic...

Instylla, a company developing liquid embolics for peripheral vascular embolotherapy, recently announced two publications that evaluated the Embrace hydrogel embolic system (HES) in preclinical...